Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

Abstract

This cohort study of men with mCRPC found higher frequency of MMRD or MSI-H and lower frequency of PTEN and TMPRSS alterations in Black men compared with White men. Although Black men received targeted therapy less frequently than White men, no differences were observed in clinical outcomes.